BioLineRx (BLRX) Assets Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.86% |
| Sep 30, 2025 | -2.87% |
| Jun 30, 2025 | -3.97% |
| Mar 31, 2025 | -1.60% |
| Dec 31, 2024 | -6.20% |
| Sep 30, 2024 | -1.62% |
| Jun 30, 2024 | 0.84% |
| Mar 31, 2024 | -5.26% |
| Dec 31, 2023 | 2.60% |
| Sep 30, 2023 | 2.64% |
| Jun 30, 2023 | 2.45% |
| Mar 31, 2023 | 4.13% |
| Dec 31, 2022 | 4.61% |
| Sep 30, 2022 | 4.31% |
| Jun 30, 2022 | 1.48% |
| Mar 31, 2022 | 12.70% |
| Dec 31, 2021 | 15.89% |
| Sep 30, 2021 | 15.50% |
| Jun 30, 2021 | 14.86% |
| Mar 31, 2021 | 11.30% |
| Dec 31, 2020 | -1.62% |
| Sep 30, 2020 | -3.51% |
| Jun 30, 2020 | -1.91% |
| Mar 31, 2020 | -4.66% |
| Dec 31, 2019 | 8.15% |
| Sep 30, 2019 | 13.13% |
| Jun 30, 2019 | 12.11% |
| Mar 31, 2019 | 11.55% |
| Dec 31, 2018 | 22.95% |
| Sep 30, 2018 | 15.75% |
| Jun 30, 2018 | 15.72% |
| Mar 31, 2018 | 12.80% |
| Dec 31, 2017 | 20.17% |